Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
9%
Ph not_applicable
10
91%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Other(3)

Detailed Status

Completed6
unknown3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (9.1%)
N/A10 (90.9%)

Trials by Status

not_yet_recruiting218%
completed655%
unknown327%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11